Safety Profile and Side Effects expected with orforglipron & Wegovy oral tablets Side effects are expected to resemble the GLP1 class, especially gastrointestinal effects
Why it matters: The program is designed for people with a BMI of 21 or higher, including many in the healthy weight range, as defined by the CDC (BMI of 18.5 to 24.9)
This dietary supplement is sometimes taken intravenously (through an IV) in a clinical setting
It is commonly known as the mother of all antioxidants and is composed of three essential amino acids: glycine, cysteine, and glutamic acid
If those results hold up, an FDA submission would follow, and approval could come sometime in 2026 or 2027
Chan et al., 2020), type II diabetes (Pan et al., 2011), and early mortality (Schwingshackl et al., 2017b